Healthcare

The healthcare sector is defined by high barriers to entry, long product development cycles, and asymmetric payoff structures driven by clinical success and regulatory outcomes. I am drawn to healthcare because returns are shaped by pipeline depth, therapeutic differentiation, pricing durability, and capital discipline, creating opportunities where fundamental research and probability-weighted valuation drive long-term investment outcomes.